# Study of Azacitidine to Treat Relapsed or Refractory Multiple Myeloma

> **NCT00412919** · PHASE2 · TERMINATED · sponsor: **Bayside Health** · enrollment: 7 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Azacitidine

## Key facts

- **NCT ID:** NCT00412919
- **Lead sponsor:** Bayside Health
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-12
- **Primary completion:** 2008-11
- **Final completion:** 2008-11
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Lack of efficacy
- **Last updated:** 2013-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00412919

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00412919, "Study of Azacitidine to Treat Relapsed or Refractory Multiple Myeloma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00412919. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*